Latest filing published 15 May 2024 for Teva Pharmaceutical Industries Ltd, €236k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Vikki L. Conway: trading record in brief
This profile gathers the share dealings of Vikki L. Conway in Teva Pharmaceutical Industries Ltd. In total, 9 filings cover trades dated from 28 February 2024 to 13 May 2024.
The open-market record consists of 5 sales worth €314k, with no purchase. Outside the open market, there are 4 option exercises.
The latest filing, published on 15 May 2024, reports an open-market sale of €236k in Teva Pharmaceutical Industries Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Vikki L. Conway
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,219 shares@ US$16.7427100.0% of flowOrdinary SharesSEC:0000950170-24-060065:0
- 4,954 sharesOrdinary SharesSEC:0000950170-24-027973:0
- 5,179 sharesOrdinary SharesSEC:0000950170-24-026098:0
- 4,294 sharesOrdinary SharesSEC:0000950170-24-023520:0
4 of 4 declarations
